- Home
- A-Z Publications
- Current Hypertension Reviews
- Previous Issues
- Volume 2, Issue 4, 2006
Current Hypertension Reviews - Volume 2, Issue 4, 2006
Volume 2, Issue 4, 2006
-
-
Renal Ischemia: How Commonly Does it Cause Renal Failure?
Authors: Renee Dua, Mitra K. Nadim, Jerry Soung and Vito M. CampeseThe prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) are steadily increasing. This phenomenon is in part linked to the aging of the US population, in part to the increasing prevalence of obesity, diabetes and related renal diseases. Some believe that renal ischemia may be a frequent cause of CKD and ESRD, but the prevalence of this condition is difficult to ascertain due to limitations of ava Read More
-
-
-
Perivascular Inflammation and Hypertensive Cardiovascular Remodeling
Authors: Hisashi Kai, Fumitaka Kuwahara, Keisuke Tokuda and Tsutomu ImaizumiMyocardial fibrosis has drawn an attention as the pathogenesis of impaired diastolic function in hypertensive hearts. However, the mechanisms whereby hypertension provokes myocardial fibrosis are not fully understood. Recently, we have demonstrated that Wistar rat with a suprarenal aortic constriction is a model of cardiac hypertrophy associated with preserved systolic, but impaired diastolic function. In this model, a r Read More
-
-
-
Isolated Systolic Hypertension: Epidemiology, Pathogenesis and Treatment
Authors: Danny Dvir, Yehonatan Sharabi and Ehud GrossmanIsolated systolic hypertension (ISHTN) is rapidly rising in prevalence, largely due to the advancing age of the population and it will soon become the most common type of hypertension. Untreated patients with merely borderline ISHTN already have a 50% grater risk for cardiovascular complications. Several studies demonstrated that treating ISHTN is beneficial. However, such treatment could cause a potential harm by Read More
-
-
-
Context-Dependency of Relations Between Cardiovascular Phenotypes and Genes Involved in Sodium Homeostasis: Findings from the European Project on Genes in Hypertension
Authors: Tatiana Kuznetsova, Jan A. Staessen, Eva Brand, Marcin Cwynar, Katarzyna Stolarz, Lutgarde Thijs, Valerie Tikhonoff, Wiktoria Wojciechowska, Speranta Babeanu, Stefan-Martin Brand-Herrmann, Edoardo Casiglia, Jan Filipovsky, Tomasz Grodzickid, Yuri Nikitin, Jan Peleka, Harry Struijker-Boudier, Giuseppe Bianchi and Kalina Kawecka-JaszczHypertension is a chronic age-related disorder, affecting nearly 20% of all adult Europeans. This disease entails debilitating cardiovascular complications and is the leading cause for drug prescriptions in Europeans older then 50 years. Intensive research over the past two decades failed so far to identify common genetic polymorphisms with major impact on blood pressure or associated cardiovascular phenotypes, sugge Read More
-
-
-
Roles of Adrenomedullin in Hypertension and Hypertensive Organ Damage
Authors: Johji Kato, Kazuo Kitamura and Tanenao EtoAdrenomedullin (AM) is a bioactive peptide having a wide range of biological actions such as vasodilatation, natriuresis, diuresis and inhibition of aldosterone secretion. Various organs and tissues, including the myocardium, vascular wall and kidneys, produce AM, and AM is also present in the bloodstream. Plasma levels of AM were elevated in patients with essential or secondary hypertension as compared with normotensive c Read More
-
-
-
Sympathetic Overactivity in Patients with Chronic Renal Failure - The Culprit of Increased Cardiovascular Mortality?
Authors: Martin Hausberg, Uta Hillebrandt, Detlef Lang, Andrea Levers and Markus KoschTonic activation of the sympathetic nervous system is a major factor contributing to hypertension in patients with chronic renal failure. Besides its role in blood pressure regulation, sympathetic overactivity causes structural and functional alterations of the myocardium and large artery walls. Altogether, these factors contribute substantially to the increased cardiovascular morbidity and mortality in patients with chronic renal d Read More
-
-
-
Benign Prostatic Hyperplasia and Clinical Prostate Cancer - Two New Components of the Metabolic Syndrome
More LessThe metabolic syndrome is a common generator of diseases in countries with western civilization lifestyles. Type 2 diabetes, atherosclerotic disease manifestations, hypertension, obesity, dyslipidaemia, hyperuricaemia, hyperinsulinaemia, dysfibrinolysis and microalbuminuria are considered to be established components of the metabolic syndrome. A clinical observation that obese and/or diabetic men appeared to have a greater p Read More
-
-
-
Role of Renin-Angiotensin System in Vascular Endothelial Dysfunction of Pregnancy-Induced Hypertension
Authors: Keiichi Matsubara, Yuko Matsubara and Masaharu ItoDuring pregnancy, the renin-angiotensin system (RAS) plays an important role in regulating the markedly expanded circulating blood volume in the uteroplacental circulation. RAS is activated during normal pregnancy; however, blood pressure decreases from the 1st trimester to the 2nd trimester. Vascular responsiveness to angiotensin II (AngII) decreases early in pregnancy; on the other hand, pregnant women who subs Read More
-
-
-
Pre-eclampsia Versus Cardiovascular Disease Versus CRP
Authors: Luis Belo, Alice Santos-Silva, Alexandre Quintanilha and Irene RebeloPre-eclampsia (PE), a hypertensive disorder of human pregnancy, shares some similarities with atherosclerosis and some studies support the theory that PE may work as a marker of increased cardiovascular risk later in life. Atherosclerosis is an inflammatory disease and raised C-reactive protein (CRP) levels have emerged as a powerful marker in predicting cardiovascular events. PE may represent an exacerbated form of Read More
-
-
-
Pathophysiological Roles of Renin-Angiotensin System on Erythropoietic Action
Authors: Hideki Kato, Masaomi Nangaku, Akiyoshi Fukamizu and Toshiro FujitaThe renin-angiotensin system (RAS) has been known to exert various actions on diverse target tissues such as kidney, heart, vascular system, and brain as well as blood pressure regulation and fluid homeostasis. In addition, various animal experiments and clinical studies suggested a role of RAS on the erythropoiesis. In RAS activated clinical situations such as posttransplant erythrocytosis, renin secreting tumors, and renal ar Read More
-
Volumes & issues
-
Volume 21 (2025)
-
Volume 20 (2024)
-
Volume 19 (2023)
-
Volume 18 (2022)
-
Volume 17 (2021)
-
Volume 16 (2020)
-
Volume 15 (2019)
-
Volume 14 (2018)
-
Volume 13 (2017)
-
Volume 12 (2016)
-
Volume 11 (2015)
-
Volume 10 (2014)
-
Volume 9 (2013)
-
Volume 8 (2012)
-
Volume 7 (2011)
-
Volume 6 (2010)
-
Volume 5 (2009)
-
Volume 4 (2008)
-
Volume 3 (2007)
-
Volume 2 (2006)
-
Volume 1 (2005)
Most Read This Month
Article
content/journals/chyr
Journal
10
5
false
en
